- Home
- UGI vs BPMC Comparison
UGI vs BPMC Comparison
Compare UGI & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGI
- BPMC
- Stock Information
- Founded
- UGI 1940
- BPMC 2008
- Country
- UGI United States
- BPMC United States
- Employees
- UGI N/A
- BPMC N/A
- Industry
- UGI Natural Gas Distribution
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- UGI Utilities
- BPMC Health Care
- Exchange
- UGI Nasdaq
- BPMC Nasdaq
- Market Cap
- UGI 6.9B
- BPMC 5.8B
- IPO Year
- UGI N/A
- BPMC 2015
- Fundamental
- Price
- UGI $32.65
- BPMC $87.66
- Analyst Decision
- UGI Buy
- BPMC Buy
- Analyst Count
- UGI 2
- BPMC 22
- Target Price
- UGI $27.50
- BPMC $124.48
- AVG Volume (30 Days)
- UGI 2.4M
- BPMC 1.1M
- Earning Date
- UGI 05-07-2025
- BPMC 05-01-2025
- Dividend Yield
- UGI 4.59%
- BPMC N/A
- EPS Growth
- UGI N/A
- BPMC N/A
- EPS
- UGI 2.55
- BPMC N/A
- Revenue
- UGI $7,119,000,000.00
- BPMC $508,824,000.00
- Revenue This Year
- UGI $6.27
- BPMC $44.85
- Revenue Next Year
- UGI $8.25
- BPMC $32.06
- P/E Ratio
- UGI $12.78
- BPMC N/A
- Revenue Growth
- UGI N/A
- BPMC 104.04
- 52 Week Low
- UGI $22.01
- BPMC $73.04
- 52 Week High
- UGI $34.49
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- UGI 52.59
- BPMC 53.93
- Support Level
- UGI $32.26
- BPMC $83.27
- Resistance Level
- UGI $33.31
- BPMC $86.85
- Average True Range (ATR)
- UGI 1.01
- BPMC 4.35
- MACD
- UGI 0.11
- BPMC 0.91
- Stochastic Oscillator
- UGI 80.87
- BPMC 98.98
About UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.